Partner with us
We’reÌýcommitted to building sustainable relationships across the scientific and business communitiesÌýthat help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal ofÌýadvancingÌýhuman health.
We’reÌýcommitted to building sustainable relationships across the scientific and business communitiesÌýthat help us combine transformative advances in the understanding of human disease with the science of therapeutics, all with the goal ofÌýadvancingÌýhuman health.
Collaboration defines our culture
We know that collaborating with the world’s experts is a cornerstone to solving some of science’s most difficult problems.ÌýCollaborationÌýis one of our core valuesÌýat Vertex — it defines our culture.
Externally, our collaborations with companies, academia, research organizations and nonprofit organizations help drive scientific innovation and the development of new medicines.
Internally, it creates an environment that encourages the open exchange of ideas and provides the freedom for our talented employees to explore new scientific concepts. Our Vertex Opportunities for Intrapreneurship & Corporate Evolution (VOICE) program is a great example.ÌýCheck it out here.
Partnerships enhance scientific innovation
To supportÌýourÌýmission, we seek external partnerships that promote scientific innovation, and we’re focused on creating relationships that are grounded in deep biological knowledge of a disease and target.ÌýWe believe that innovation should not be limited to opportunities basedÌýsolely on specific stages of development orÌýonÌýparticular treatmentÌýmodalities.
Ìý
Our current priorities include:
-
SupportingÌýVertex’sÌýcystic fibrosis strategy of bringing innovative medicines to patientsÌýby complementing our existing research efforts and clinical assets withÌýadditional toolsÌýand/or technologies.Ìý
-
Diversifying our portfolio with potentially transformative medicines in diseasesÌýwhere there isÌýa high unmet need.Ìý
-
Leveraging cutting-edge technology platforms to accelerate the discovery of new disease targets, compounds, delivery mechanisms and potential treatment modalities.Ìý
-
Maximizing the potential ofÌýVertexÌýassets by using strategic collaborations and licensing opportunities to enable speedy and thorough development.Ìý
Vertex is a trusted partner
We value developing strategic relationshipsÌýthat are mutually beneficial. Our approach is to create successful partnerships with well-articulated principles and value propositions. Our portfolio of alliances consists of a variety of collaboration models to meetÌýtheÌýdifferent needs of our partners.Ìý
Vertex works to maximize the value of our partnerships for both organizations, seeking to make decisions that align our common goals and, most importantly, bring benefits to patients as quickly as possible. We work collaboratively to make informed and strategic decisions to rapidly progress our partnered programs.
Areas of interest
We're actively exploring all approaches that may change the treatment of a serious disease where no adequate treatment currently exists. We are seeking technologies that will enable exploration of new diseases or disease targets.
Please also contact us if you'd like to explore a potential partnership related to any of the following:
Our global network of innovation
Targets and Human Cell Models
Genomics plc
announcement
Innovation in Small Molecule Therapeutics
X-Chem
announcement
Kymera
announcement
Ribometrix
announcement
Skyhawk Therapeutics
announcement
Stablix
Ìýannouncement
Cell and Genetic Therapies
CRISPR Therapeutics
Ìýannouncement
Ìýannouncement
Moderna
announcement
announcement
Ìý
Affinia Therapeutics
announcement
Arbor Biotechnologies
announcement
Mammoth Biosciences
announcement
Obsidian Therapeutics
announcement
Verve Therapeutics
announcement
Entrada Therapeutics
announcement
Tevard Biosciences
announcement
ImmunoGen
announcement
Lonza
announcement